(Q44740263)

English

Effect of fluticasone propionate nasal spray on bioavailability of intranasal hydromorphone hydrochloride in patients with allergic rhinitis

scientific article published in January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Effect of fluticasone propionate nasal spray on bioavailability of intranasal hydromorphone hydrochloride in patients with allergic rhinitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

fluticasone propionate

1 reference

based on heuristic

inferred from title

bioavailability

1 reference

based on heuristic

inferred from title

author name string

George A Davis

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Anita C Rudy

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sanford M Archer

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Daniel P Wermeling

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Patrick J McNamara

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

26-32

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Nasal administration of opioids for pain management in adults

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Optimising postoperative pain management in the ambulatory patient.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Pharmacokinetics of intranasal alfentanil.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

[Pharmacokinetics of intranasal Fentanyl.].

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Comparison of intravenous and intranasal sufentanil absorption and sedation.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Pharmacokinetic comparison of intravenous and intranasal administration of oxycodone.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

The systemic availability of buprenorphine administered by nasal spray

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Disposition of nasal, intravenous, and oral methadone in healthy volunteers

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Hydromorphone transfer into breast milk after intranasal administration

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Pharmacokinetics and bioavailability of single-dose intranasal hydromorphone hydrochloride in healthy volunteers

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Relative Analgesic Potencies of Morphine and Hydromorphone in Postoperative Pain

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Hydromorphone: pharmacology and clinical applications in cancer patients.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Pharmacokinetics and Bioavailability of Hydromorphone Following Intravenous and Oral Administration to Human Subjects

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Absolute bioavailability of hydromorphone after peroral and rectal administration in humans: saliva/plasma ratio and clinical effects

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

7. Rhinitis and sinusitis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Intranasal corticosteroids for allergic rhinitis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Intranasal fluticasone propionate. A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Mode of action of intranasal corticosteroids

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Mucosal and systemic inflammatory changes in allergic rhinitis and asthma: a comparison between upper and lower airways.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Influence of experimental rhinitis on the gonadotropin response to intranasal administration of buserelin.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Effect of intranasal histamine on nasal mucosal blood flow and the antidiuretic activity of desmopressin

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Hydromorphone levels and pain control in patients with severe chronic pain.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Intranasal fentanyl titration for postoperative pain management in an unselected population

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Intranasal meperidine titration for postoperative pain relief

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.26.34810

21 January 2018

Identifiers

10.1592/PHCO.24.1.26.34810

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44740263&oldid=2036438106"